Jadenu and Abdominal pain upper - a phase IV clinical study of FDA data
Summary:
Abdominal pain upper is reported as a side effect among people who take Jadenu (deferasirox), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Exjade, and have Iron overload.
The phase IV clinical study analyzes which people have Abdominal pain upper when taking Jadenu. It is created by eHealthMe based on reports of 4,173 people who have side effects when taking Jadenu from the FDA, and is updated regularly.
What is Jadenu?
Jadenu has active ingredients of deferasirox. eHealthMe is studying from 4,176 Jadenu users. Check the latest studies of Jadenu.
What is Abdominal pain upper?
Abdominal pain upper is found to be associated with 2,985 drugs and 4,485 conditions by eHealthMe. Check the latest studies of Abdominal pain upper.
4,173 people reported to have side effects when taking Jadenu.
Among them, 169 people (4.05%) have Abdominal pain upper.
Among these 169 people:
How long have people been on Jadenu when they have Abdominal pain upper? *
What is the gender of people who have Abdominal pain upper when taking Jadenu? *
What is the age of people who have Abdominal pain upper when taking Jadenu? *
What are other drugs people take besides Jadenu? *
What are other side effects people have besides Abdominal pain upper? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Jadenu and have Abdominal pain upper?
- Check whether Abdominal pain upper is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Jadenu:
- Jadenu (4,176 reports)
Abdominal pain upper treatments and more:
- Abdominal pain upper (243,364 reports)
How severe was Abdominal pain upper and when was it recovered:
Expand to all the drugs that have ingredients of deferasirox:
- Abdominal pain upper and drugs with ingredients of deferasirox (1,144 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Jadenu:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Abdominal pain upper:
- Abdominal pain upper (2,985 drugs)
Browse all the conditions that are associated with Abdominal pain upper:
- Abdominal pain upper (4,485 conditions)
Related publications that referenced our studies
- Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
- Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
- Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
- Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
- Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
- Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
- Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
- Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
- Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
- Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on deferasirox (the active ingredients of Jadenu) and Jadenu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Claritin and Veletri - a second ago
- Coq vs. Levothyroxine Sodium, side effect and effectiveness comparison - 8 seconds ago
- Could Augmentin cause Left Ventricular Hypertrophy? - 8 seconds ago
- Drug interactions of Glyburide and Sinemet - 8 seconds ago
- Drug interactions of Midazolam and Hydroxychloroquine Sulfate - 17 seconds ago
- Imitrex vs. Compazine, side effect and effectiveness comparison - 18 seconds ago
- Could Mellaril cause Pharyngitis? - 21 seconds ago
- Could Azithromycin cause Joint Pain? - 21 seconds ago
- Drug interactions of Warfarin Sodium and Pramipexole Dihydrochloride - 22 seconds ago
- Could Feldene cause Swelling? - 26 seconds ago